15-Minute Coronavirus Test Announced by Roche

Roche Diagnostics announced on September 1, 2020, that it will launch a SARS-CoV-2 Rapid Antigen Test, in late September, in certain markets, and intends to file for Emergency Use Authorization to the U.S. FDA. The SARS-CoV-2 Rapid Antigen Test is for use in point of care settings for both symptomatic and asymptomatic people, with results typically ready in just 15 minutes.

This innovative test can enable healthcare professionals to identify a SARS-CoV-2 infection in people suspected of carrying the coronavirus.

Thomas Schinecker, CEO of Roche, stated, “Testing continues to be an important focus for many countries, especially in the upcoming flu season, it is important to know whether a person has SARS-CoV-2 or the flu to ensure the right course of treatment."

"COVID-19 testing solutions that provide healthcare professionals and patients with a quick answer regarding their infection status are critical to contain the community-spread of the COVID-19 virus."